Literature DB >> 18592401

Tragedy and Grenzsituationen in genetic prediction.

Kjetil Rommetveit1, Rouven Porz.   

Abstract

Philosophical anthropologies that emphasise the role of the emotions can be used to expand existing notions of moral agency and learning in situations of great moral complexity. In this article we tell the story of one patient facing the tough decision of whether to be tested for Huntington's disease or not. We then interpret her story from two different but compatible philosophical entry points: Aristotle's conception of Greek tragedy and Karl Jaspers' notion of Grenzsituationen (boundary situations). We continue by indicating some ways in which these two positions may be used for reflecting upon different perspectives involved in clinical decision-making, those of patients, clinicians and bioethicists. We conclude that the ideas we introduce can be used as hermeneutic tools for situating learning and dialogue within a broader cultural field in which literature and art may also play important roles.

Entities:  

Mesh:

Year:  2008        PMID: 18592401     DOI: 10.1007/s11019-008-9139-x

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  4 in total

1.  Catharsis and moral therapy II: An Aristotelian account.

Authors:  Jan Helge Solbakk
Journal:  Med Health Care Philos       Date:  2006

2.  Genetic information in the age of genohype.

Authors:  Péter Kakuk
Journal:  Med Health Care Philos       Date:  2006

3.  The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.

Authors:  S E Andrew; Y P Goldberg; B Kremer; H Telenius; J Theilmann; S Adam; E Starr; F Squitieri; B Lin; M A Kalchman
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

4.  'You don't make genetic test decisions from one day to the next'--using time to preserve moral space.

Authors:  Jackie Leach Scully; Rouven Porz; Christoph Rehmann-Sutter
Journal:  Bioethics       Date:  2007-05       Impact factor: 1.898

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.